(Q34349055)

1 August 2017

1 reference

title

Signal transduction inhibition: results from phase I clinical trials in chronic myeloid leukemia (English)

1 reference

1 August 2017

phase I clinical trial

0 references

chronic myeloid leukemia

0 references

1 reference

Druker B

1

1 reference

1 August 2017

1 July 2001

1 reference

1 August 2017

Seminars in Hematology

1 reference

1 August 2017

38

1 reference

1 August 2017

9-14

1 reference

1 August 2017

3 Suppl 8

1 reference

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990112-X

7 January 2021

10.1016/S0037-1963(01)90112-X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11526596